[The psychopharmacological significance in psychosomatic medicine of a new monoamine-oxidase inhibitor].
D007490:Iproniazid / Q000031:analogs & derivatives; D008996:Monoamine Oxidase Inhibitors; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011600:Psychopharmacology; D011611:Psychosomatic Medicine
D008996:Monoamine Oxidase Inhibitors; D007490:Iproniazid; D010088:Oxidoreductases
IPRONIAZID/related compounds; OXIDASES/antagonists; PSYCHOSOMATIC MEDICINE